Equities Analysts Set Expectations for ARDT FY2024 Earnings

Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Equities research analysts at KeyCorp lowered their FY2024 earnings per share estimates for Ardent Health Partners in a report released on Monday, January 6th. KeyCorp analyst M. Gillmor now anticipates that the company will earn $1.20 per share for the year, down from their prior estimate of $1.28. KeyCorp has a "Strong-Buy" rating on the stock. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.23 per share. KeyCorp also issued estimates for Ardent Health Partners' Q4 2024 earnings at $0.44 EPS, Q1 2025 earnings at $0.55 EPS, Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $2.05 EPS and FY2026 earnings at $2.27 EPS.

A number of other equities research analysts have also recently issued reports on ARDT. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Leerink Partners upped their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a report on Tuesday, November 12th. Bank of America downgraded shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $22.00 to $19.00 in a report on Wednesday, November 6th. Stephens restated an "overweight" rating and set a $24.00 price target on shares of Ardent Health Partners in a report on Thursday, September 19th. Finally, Truist Financial lowered their price target on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research report on Monday. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $22.00.

Ardent Health Partners Trading Up 0.3 %

NYSE:ARDT traded up $0.05 during trading hours on Thursday, reaching $16.41. The company's stock had a trading volume of 97,685 shares, compared to its average volume of 235,177. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72. The business has a 50-day moving average of $16.62. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $42,000. Financial Management Professionals Inc. acquired a new stake in Ardent Health Partners in the 3rd quarter valued at $50,000. MetLife Investment Management LLC bought a new stake in Ardent Health Partners in the third quarter valued at $135,000. JPMorgan Chase & Co. acquired a new position in Ardent Health Partners during the third quarter worth $154,000. Finally, Quadrature Capital Ltd bought a new position in shares of Ardent Health Partners during the third quarter valued at $229,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.